Radiological findings of complications after lung transplantation. by Habre, C. et al.
PICTORIAL REVIEW
Radiological findings of complications after lung transplantation
Céline Habre1 & Paola M. Soccal2,3,4 & Frédéric Triponez4,5 & John-David Aubert6,7 & Thorsten Krueger7,8 &
Steve P. Martin1 & Joanna Gariani1 & Jean-Claude Pache4,9 & Frédéric Lador2,3,4 & Xavier Montet1,4 &
Anne-Lise Hachulla1,3,4
Received: 22 March 2018 /Revised: 22 June 2018 /Accepted: 4 July 2018 /Published online: 15 August 2018
# The Author(s) 2018
Abstract
Complications following lung transplantation may impede allograft function and threaten patient survival. The five
main complications after lung transplantation are primary graft dysfunction, post-surgical complications, alloimmune
responses, infections, and malignancy. Primary graft dysfunction, a transient ischemic/reperfusion injury, appears as a
pulmonary edema in almost every patient during the first three days post-surgery. Post-surgical dysfunction could be
depicted on computed tomography (CT), such as bronchial anastomosis dehiscence, bronchial stenosis and
bronchomalacia, pulmonary artery stenosis, and size mismatch. Alloimmune responses represent acute rejection or
chronic lung allograft dysfunction (CLAD). CLAD has three different forms (bronchiolitis obliterans syndrome,
restrictive allograft syndrome, acute fibrinoid organizing pneumonia) that could be differentiated on CT. Infections
are different depending on their time of occurrence. The first post-operative month is mostly associated with
bacterial and fungal pathogens. From the second to sixth months, viral pneumonias and fungal and parasitic oppor-
tunistic infections are more frequent. Different patterns according to the type of infection exist on CT. Malignancy
should be depicted and corresponded principally to post-transplantation lymphoproliferative disease (PTLD). In this
review, we describe specific CT signs of these five main lung transplantation complications and their time of
occurrence to improve diagnosis, follow-up, medical management, and to correlate these findings with pathology
results.
Key Points
• The five main complications are primary graft dysfunction, surgical, alloimmune, infectious, and malignancy complications.
• CT identifies anomalies in the setting of unspecific symptoms of lung transplantation complications.
• Knowledge of the specific CT signs can allow a prompt diagnosis.
• CT signs maximize the yield of bronchoscopy, transbronchial biopsy, and bronchoalveolar lavage.
• Radiopathological correlation helps to understand CT signs after lung transplantation complications.
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Abbreviations
AFOP Acute fibrinous organizing pneumonia
BOS Bronchiolitis obliterans syndrome
CLAD Chronic lung allograft dysfunction
CMV Cytomegalovirus
CT Computed tomography
PGD Primary graft dysfunction
PTLD Post-transplantation lymphoproliferative disease
RAS Restrictive allograft syndrome
Introduction
Complications following transplantation may impede allo-
graft function and threaten patient survival. Five principal
complications have been described: primary graft dysfunction
(PGD), post-surgical complications, alloimmune responses,
infections, and malignancy [1, 2].
Improvement in surgical procedures, in particular bronchial
anastomosis techniques and the endoscopic management of
stenosis or leakage, has contributed to reduce airway compli-
cations [3, 4]. Furthermore, systematic infection prophylaxis
and a trend for virus serology matching have significantly
reduced post-operative morbidity and improved long-term
survival with reduced chronic allograft dysfunction [5].
Nevertheless, these advances are currently unable to
completely prevent these complications and clinical
follow-up is required with regular lung function assess-
ments, bronchoscopy exams, and computed tomography
(CT) scans.
Chest X-ray is performed systematically every year or when-
ever clinical symptoms occur. Chest CT is a key tool in active
follow-up or when chest X-ray is abnormal by allowing early
identification and diagnostic clues in the setting of unspecific
acute respiratory symptoms, regardless of their origin.
Knowledge of the specific CT signs can improve medical man-
agement by allowing a prompt diagnosis, by guiding broncho-
scopic procedures for bronchoalveolar lavage and transbronchial
biopsy. Likewise, the decline of lung functionmay not always be
discriminative between infection or rejection, either acute or
chronic, and further investigation by chest CT may help clini-
cians in establishing a diagnosis before more invasive broncho-
scopic procedures.
Complications after lung transplantation vary depending
on the delay of their occurrence. Figure 1 summarizes the
mean time of occurrence and the greatest incidence of com-
plications depending on the time after the procedure and ac-
cording to the literature [4, 6, 7].
In this review, we describe specific CT signs of these five
main lung transplantation complications and their time of oc-
currence to improve diagnosis, follow-up, medical
Fig. 1 Onset of complications following lung transplantation. Adapted from Ng et al. 2009 [4]. CLAD: chronic lung allograft dysfunction; PGD:
primary graft dysfunction; PTLD: post-transplantation lymphoproliferative disease; D: day; W: week; M: month; Y: year
710 Insights Imaging (2018) 9:709–719
management, guide bronchoscopic procedures, and to corre-
late these findings with pathology results.
Primary graft dysfunction
The first lung transplantation complication to occur is primary
graft dysfunction. This corresponds to a transient ischemic/
reperfusion injury that appears as a pulmonary edema in al-
most every patient during the first three days post-surgery [8].
PGD is clinically assessed and graded according to the ratio of
arterial oxygen pressure to inspired oxygen concentration (PaO2/
FiO2) and presence of lung allograft consolidations on the chest
radiograph [4]. Ischemia reperfusion injury should be considered
after the exclusion of an infectious or cardiogenic etiology. CT
signs are pleural or scissural effusions, septal and
peribronchovascular thickening, perihilar consolidations, without
cardiomegaly, and sparing of the native lung in cases of single
lung transplantation (Fig. 2) [7]. It is interesting to note that
exudative and hemorrhagic pleural effusions are a normal finding
Table 1 Computed tomography (CT) findings of post-surgical complications
Bronchial anastomosis
dehiscence
Bronchial stenosis Bronchomalacia Pulmonary artery
stenosis
Size mismatch
Time of occurrence 2–4 weeks 2–4 months 2–4 months 0–2 weeks 0–2 weeks
Clinical keys Dyspnea and recurrent
infections
Dyspnea
Recurrent post-obstructive
infections
Dyspnea
Recurrent post-obstructive
infections
Dyspnea and chest pain Dyspnea
CT signs Focal parietal defect
Pneumomediastinum
Pneumothorax
Subcutaneous emphysema
Fixed reduction of bronchial
lumen diameter
Dynamic collapse
of the bronchus on
expiratory acquisition
Reduced caliber
Homolateral hypoperfusion
Dilatation of main PA and
right cavities
Allograft atelectasis
Fig. 3 Bronchial anastomosis
dehiscence. Air collection
anterior to the right bronchial
suture (arrow) (a). Indirect signs
include persistent pneumothorax
(arrow) and new subcutaneous
emphysema (arrowheads) (b)
Fig. 2 Primary graft dysfunction.
Septal, scissural, and
peribronchovascular thickening
(arrowheads) and pleural
effusions (stars)
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early after thoracic surgery that may persist until the second
month.
Post-surgical dysfunction
Four different post-surgical complications have been de-
scribed: bronchial anastomosis dehiscence, bronchial ste-
nosis and bronchomalacia, pulmonary artery stenosis, and
size mismatch, as listed in Table 1.
Bronchial dehiscence of the anastomosis results mainly
from bronchial ischemia because of the absence of
reanastomosis of bronchial arteries [9]. It may appear as
a focal parietal defect or may be suggested indirectly by
pneumomediastinum, pneumothorax, or subcutaneous em-
physema 2 weeks after surgery (Fig. 3) [10].
Afterwards, lesions of bronchial healing from ischemia
may also occur, either as bronchial anastomosis stenosis
Fig. 5 Pulmonary artery stenosis.
Dyspnea and chest pain 3 months
after surgery. Stenosis of the left
PA (arrow) responsible for
dilatation of the main PA (star)
(a) and, as consequences, a wide
hypoperfusion of the left lung in
the pale yellow color area on the
perfusion map (arrows) (b)
Fig. 4 Bronchial stenosis. Dyspnea and recurrent infections at 6 months
after lung transplantation. Narrowing of the anastomosis of the right main
bronchus with minimal intensity projection (arrow)
Fig. 6 Donor–recipient size mismatch. Persisting dyspnea. Atelectasis of lower lobes (arrows in a) with comet-tail sign (arrows in b)
712 Insights Imaging (2018) 9:709–719
Fig. 7 Acute rejection A1.
Ground-glass opacities (stars)
and interlobular thickening
(arrowheads) (a) in minimal
acute rejection, characterized by
sparse perivascular mononuclear
infiltrates (arrows) (b)
Fig. 8 Acute rejection A2. Subtle ground-glass opacities (arrows in a) better detected with minimal intensity projection (arrows in b) in mild acute
rejection, with more frequent perivascular mononuclear infiltrates and endothelialitis (arrow in c)
Table 2 Specific CT pattern with alloimmune complications
Alloimmune responses Acute rejection BOS RAS AFOP
Time of occurrence 1–12 weeks 6–18 months 6–18 months 6–18 months
Clinical keys Acute dyspnea Chronic dyspnea, cough
Decrease in FEV1 and
FEV1/FVC ratio
Chronic dyspnea
Decrease in FEV1 and TLC
Acute dyspnea
Decrease in FEV1
CT signs Ground-glass opacities
Interlobular septal thickening
Pleural effusions
Volume loss
BObstructive phenotype^
Bronchiectasis
Bronchial thickening
Expiratory air-trapping
BRestrictive phenotype^
Bronchiectasis
Peripheral consolidations or
ground-glass opacity
Subpleural thickening
Architectural distortion
Upper lobe predominance
Volume loss
Inter-/intralobular septal thickening
Peripheral ground-glass opacity and
consolidations
AFOP: acute fibrinous organizing pneumonia; BOS: bronchiolitis obliterans syndrome; FEV1: forced expiratory volume in 1 s; FVC: forced vital
capacity; RAS: restrictive allograft syndrome; TLC: total lung capacity
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or bronchomalacia [7]. Bronchial stenosis is a fixed re-
duc t ion o f t he b ronch ia l l umen d iame te r and
bronchomalacia appears as a dynamic collapse of the
bronchus on expiratory acquisition. Both can cause recur-
rent post-obstructive infections of the involved ventilated
regions [4, 5, 7] (Fig. 4).
Pulmonary artery stenosis could be depicted by a sig-
nificant difference of the pulmonary arterial diameter be-
tween donor and receiver, responsible for ipsilateral pul-
monary hypoperfusion depicted on the iodine cartography
perfusion map with dual-energy CT (Fig. 5) [11].
Dilatation of the main pulmonary artery and right heart
cavities have been described.
Size mismatch between the donor lung and the recipient
thoracic cage can cause areas of atelectasis, or even complete
collapse of the allograft in extreme cases (Fig. 6).
Alloimmune responses
Lung-transplanted patients are at particular risk for
alloimmune responses. Acute rejection and chronic lung allo-
graft dysfunction (CLAD) have been described and Table 2
summarizes the alloimmune response findings on CT.
Acute allograft rejection
Acute allograft rejection occurs mostly during the first
year following transplantation in almost 30% of recipi-
ents and may occur as repetitive episodes [1]. Prompt
diagnosis and management are necessary because early
and repeated exacerbations of acute rejection may lead
to CLAD. Many attempts have been made to identify
specific signs of acute rejection on CT, but, considered
Fig. 9 Acute rejection A3. New
pleural effusion (arrow) (a) as the
only finding in moderate acute
rejection, histologically defined
as dense perivascular
mononuclear infiltrates with
peribronchiolar and airspaces
extension (arrows) (b)
Fig. 10 Bronchiolitis obliterans syndrome (BOS). Chronic dyspnea with
obstructive pattern at functional tests. Bronchiectases, bronchial
thickening (arrowheads) (a) and mosaic perfusion on minimal intensity
projection reconstruction (radiolucent areas; stars) (b) in constrictive
bronchiolitis, characterized by submucosa fibrosis with mononuclear
infiltrates of the small airways (arrow) (c)
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individually, none seem accurate nor have a good pre-
dictive value for acute rejection and the degree of se-
verity [12]. Nevertheless, recognition and reporting of
CT signs of potential acute allograft rejection are war-
ranted to guide transbronchial biopsy for histopatholog-
ical analysis.
Typical CT signs are ground-glass opacities, pleural effu-
sions, lung volume loss, and interlobular septal thickening,
associated with graduate perivascular and interstitial mononu-
clear cells infiltration depending on the grade (from minimal
perivascular mononuclear infiltrates [grade A1] to severe in-
filtrates [grade A4]) on histopathology examination (Figs. 7,
8, and 9) [7, 13].
CLAD
The prevalence of CLAD 5 years after transplantation is 40–
50% of patients [1, 14]. CLAD has two distinct phenotypes:
obstructive, namely, bronchiolitis obliterans syndrome (BOS)
and restrictive, namely, restrictive allograft syndrome (RAS)
[15, 16]. CT scans along with lung functions may help in
distinguishing between subtypes.
Fig. 12 Restrictive allograft
syndrome (RAS). Dyspnea and
irreversible decline in forced
expiratory volume (FEV) and
total lung capacity (TLC).
Peripheral condensations and
subpleural thickening (arrows),
bronchiectasis (arrowheads) (a)
and volume loss with upper lobe
predominance (stars) (b). RAS
was confirmed by biopsy
Fig. 13 Acute fibrinoid allograft pneumonia (AFOP). Acute shortness of
breath. Intralobular septal thickening and extensive ground-glass
opacities (stars), interlobular thickening (arrowheads), and pleural
effusions (arrows), confirmed by histology
Fig. 11 BOS. Chronic dyspnea and cough. Normal parenchyma on inspiration acquisition (a) followed by air-trapping on expiration acquisition (stars)
(b) in constrictive bronchiolitis, characterized by submucosa fibrosis (arrow) (c)
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BOS is a constrictive bronchiolitis [13]. CT signs of BOS
are bronchiectasis, bronchial thickening, and air-trapping on
expiratory acquisition (Figs. 10 and 11) [4, 17–19].
Conversely, RAS is a pleuroparenchymal fibroelastosis on
histopathology [20], with a more fibrotic pattern on CT and
poorer survival. CT signs of RAS are peripheral consolida-
tions or central or peripheral ground-glass opacities, septal
or non-septal lines, subpleural thickening, bronchiectasis, ar-
chitectural distortion, and volume loss with an upper lobe
predominance (Fig. 12) [21].
Some authors have advocated acute fibrinoid organizing
pneumonia (AFOP) as a third potential form of chronic allo-
graft dysfunction, with decline of lung functions as for CLAD
but with distinct histopathology and imaging findings [22].
Inter- and intralobular septal thickening, extensive ground-
glass infiltration, and peripheral consolidations have been
Table 3 Specific CT pattern with various infections
Infectious diseases Bacterial germs Viral germs Angioinvasive aspergillosis
Time of occurrence 0–4 weeks 4 weeks to 6 months 4–18 months
Clinical keys Productive cough and high-grade
fever/sepsis
Bronchoalveolar lavage
Sputum culture
Productive cough and high-grade fever General alteration and productive cough
Bronchoalveolar lavage: branching filaments
CT signs Lobar or patchy consolidations
Air bronchogram
Branching centrilobular nodules
Cavitation
Pleural effusion
Ground-glass nodules
Tree-in-bud nodules
Peribronchovascular thickening
Interlobular septal thickening
Vascular-centered nodules
Ground-glass Bhalo sign^
Subpleural wedged ground-glass opacity or
dense consolidation
Fig. 14 Pseudomonas aeruginosa. Productive cough and high-grade
fever. Dense tree-in-bud centrilobular nodules on maximal intensity
projection reconstruction (arrows) and pleural effusion (star).
Pseudomonas aeruginosa was confirmed by sputum culture
Fig. 15 Staphylococcus epidermidis. Sepsis. Consolidation with air
bronchogram (arrow)
Fig. 16 Lung abscess. Fever of unknown origin and asthenia.
Consolidation with air–fluid level (arrow) suggestive of lung abscess.
Methicillin-susceptible S. aureus (MSSA) infection was confirmed by
bronchoalveolar lavage
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described and are consistent with a distinct histopathology
entity, either post-infectious or as a distinct form of chronic
allograft dysfunction (Fig. 13) [22].
Infections
Lung-transplanted patients are at particular risk of allograft
infections and radiologists should be aware of the epidemiol-
ogy of pneumonias according to their time of onset. Table 3
summarizes different patterns according to the type of
infection.
The aim of prompt recognition of allograft infection is to
reduce immediate morbidity related to symptomatic disease
thanks to prompt targeted therapy and to prevent failure of
anastomotic healing and long-term chronic allograft dysfunc-
tion [5].
The first post-operative month is mostly associated with
bacterial and fungal pathogens [6, 23]. Bacterial infections
are the most common. CT signs of bacterial infections include
extensive consolidations with air bronchogram, disseminated
patchy consolidations, branching centrilobular nodules
(Figs. 14 and 15), or cavitation or abscess (Fig. 16).
CT signs of angioinvasive aspergillosis are isolated or mul-
tiple vessel centered nodular consolidations with peripheral
ground-glass Bhalo sign^ consistent with hemorrhagic infarcts
(Fig. 17) [24].
From the second to sixth months, long-term immunosup-
pression of T-cells is responsible for viral pneumonias. CT
signs are ground-glass opacities or tree-in-bud nodules
Fig. 17 Angioinvasive
Aspergillus fumigatus. General
alteration and productive cough.
Solid nodule with peripheral
ground-glass opacities termed as
the Bhalo sign^ (arrow) (a).
Pathology showed branching
filaments (arrows), consistent
with angioinvasive aspergillosis
(b)
Fig. 18 Parainfluenzae
pneumonia. Sepsis. Segmental
consolidation of the right upper
lobe (arrow) (a) and left basal
ground-glass centrilobular
micronodulation (arrowheads)
(b)
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(Fig. 18). Fungal and parasitic opportunistic infections can
also occur, either from reactivation of latent germs, in partic-
ular from cytomegalovirus (CMV), or by community-
acquired or nosocomial transmission [6]. CT signs are also
ground-glass opacities, tree-in-bud nodules, or an interstitial
pattern with peribronchovascular and septal thickening [7].
After six months, immunosuppression is usually reduced
with less opportunistic infections or reactivation of latent path-
ogens. The most commonly encountered pathogens are
community-acquired viral and bacterial, or reactivation of la-
tentMycobacterium tuberculosis and other mycobacteriae [6,
7]. Individual CT signs are of limited accuracy to distinguish
between germs [24]; yet, recognition of some specific patterns
of involvement, such as consolidations with air bronchogram,
tree-in-bud, or nodules in the context of fever, may favor in-
fection over an alloimmune reaction.
Malignancy
Finally, malignancy remains an important cause of long-
term mortality, occurring in almost 25% of patients
5 years after lung transplantation [1, 2]. Malignancy
may be confined to the lung allograft or involve distant
organs. Post-transplantation lymphoproliferative disease
(PTLD) includes a spectrum from lymphoid proliferation
to monoclonal lymphoma, affecting 1.8–20% of lung-
transplanted patients, with am association with Epstein–
Barr virus infection [6, 25]. The manifestation of PTLD
includes an isolated nodule or mass of the lung allograft,
disseminated micronodules with an interstitial topogra-
phy, or mediastinal or abdominal lymphadenopathies
(Fig. 19) [25].
Skin malignancies are also predominant, including mela-
noma, reaching nearly 20% at 10 years. Other cancers could
also occur, such as primary epidermoid lung carcinoma
(Fig. 20).
Conclusion
Chest computed tomography (CT) scanning is an important
tool in the follow-up of lung transplantation, allowing the
diagnosis of pathologies depending on their time of onset in
order to improve patient management.
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Fig. 19 Post-transplantation
lymphoproliferative disease
(PTLD). Weight loss and general
alteration. Voluminous
retroperitoneal
lymphadenopathies on non-
enhanced abdominal CT
(arrowheads) (a) with increased
metabolism on FDG-PET CT
scanning (arrowheads) (b)
Fig. 20 Primary epidermoid lung carcinoma. Asymptomatic, cavitated
nodule on follow-up chest X-ray. Cavitated nodule with spiculated
margins (arrow) and pleural traction (arrowheads)
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